Ontario Advancing Innovation in the Life Sciences

The Ontario government is supporting $5.8 million in investments by two Kitchener-based medical technology companies as they expand production capacity, scale globally and commercialize their Ontario-made health technologies in the provincial and global markets. This announcement marks the first round of funding under the government’s Life Sciences Scale-Up Fund (LSSUF), and will support the goals outlined in Phase 2 of Ontario’s Life Sciences Strategy, while working in tandem with the Health Innovation Pathway to support the adoption of innovation in the health-care system.

Congratulations to Intellijoint Surgical and Vena Medical, both OBIO-affiliated companies, on being the recipients of this funding.